New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. A real-world study found these medications substantially reduced the risk of strokes and heart attacks in type 2 diabetes patients. These findings suggest a potential turning point in diabetes care, highlighting the drugs’ protective effects on the heart.
